|
![]() |
![]() |
![]() |
FULL YEAR: NUTRIEN'S SALES UP 33%, EARNINGS UP 6X TO $3.2 BILLION Feb. 17, 2022 Source: Nutrien news release SASKATOON, Saskatchewan--Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2021 results, with net earnings of $1.2 billion ($2.11 diluted net earnings per share). Fourth-quarter adjusted net earnings1 were $2.47 per share and adjusted EBITDA1 was $2.5 billion. "The advantages of Nutrien's integrated business were demonstrated in 2021 as we delivered record financial results3 and made significant progress on our long-term strategic targets, including our key sustainability priorities. We utilized the scale and reliability of our world-class supply chain and the strong execution of our teams to ensure customers had the products and services they needed, when they needed them," commented Ken Seitz, Nutrien's Interim President and CEO. "The outlook for global agriculture and crop input markets is very strong and we are well positioned to deliver significant growth in earnings and free cash flow in 2022. We will continue to advance our strategic priorities and maintain a disciplined approach to deploying capital, using our strong financial position to grow the business and return significant cash to shareholders," added Mr. Seitz. Highlights: *Nutrien generated net earnings of $1.2 billion and record adjusted EBITDA of $2.5 billion in the fourth quarter while generating $3.2 billion of net earnings ($5.52 diluted net earnings per share) and record adjusted EBITDA of $7.1 billion ($6.23 adjusted net earnings per share) for the full year of 2021. Cash flow provided by operating activities in the full year was $3.9 billion. *We prioritized the use of cash in 2021 to strengthen and reposition the balance sheet, reducing our long-term debt by $2.1 billion. We deployed $2.1 billion to dividends and share repurchases in 2021 repurchasing 15 million shares during the year under our normal course issuer bid (NCIB). To date, we have repurchased over 22 million shares under our NCIB program. Nutrien's Board of Directors approved an increase in the quarterly dividend to $0.48 per share and approved the purchase of up to 10 percent of Nutrien's outstanding common shares over a one-year period through a NCIB. The NCIB is subject to acceptance by the Toronto Stock Exchange. *Nutrien issued full-year 2022 adjusted EBITDA and adjusted net earnings per share guidance1 of $10.0 to $11.2 billion and $10.20 to $11.80 per share. Adjusted net earnings per share guidance includes our plans to allocate a minimum of $2 billion to share repurchases in 2022 on a balanced cadence throughout the year. *Nutrien Ag Solutions ("Retail") delivered record adjusted EBITDA in the fourth quarter and surpassed $1.9 billion for the full year of 2021. We exceeded nearly all of our 2023 strategic targets including a record 10.9 percent Retail adjusted EBITDA margin2 and increased our proprietary product related gross margin to more than $1 billion in 2021, an increase of 22 percent. *The reliability and efficiency of our global supply chain and strategic procurement helped drive our Retail normalized comparable store sales1 to 7 percent and Retail adjusted EBITDA per US selling location2 to $1.5 million during 2021. We closed 14 acquisitions during the year and increased our Retail digital platform sales2 to $2.1 billion. *Potash adjusted EBITDA surpassed $1 billion in the fourth quarter and increased 130 percent in the full year of 2021 to $2.7 billion. We achieved record sales volumes of 13.6 million tonnes in 2021 due to our capability to quickly ramp up production from our flexible, low-cost network of six mines. We progressed our Potash Next Generation initiatives and produced 1 million tonnes in 2021 using tele-remote and autonomous mining techniques. *Nitrogen adjusted EBITDA was $921 million in the fourth quarter of 2021 and increased 114 percent to $2.3 billion in the full year of 2021. We completed our phase 1 brownfield expansion projects on time and on budget, launched a second phase of projects and progressed decarbonization initiatives. *Phosphate adjusted EBITDA was $196 million in the fourth quarter of 2021 and increased 133 percent to $540 million in the full year of 2021. To read the entire report click here. Tweet |
![]() |
![]() |
![]() |
|
![]() |
![]() |
|
![]() |
|||||||||||||